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Abstract
Objectives: To investigate the effect of pubertal timing, assessed in adolescence, on
bone size, strength and density in men and women in early old age.
Design: A British birth cohort study with prospective indicators of pubertal timing based
on age at menarche, clinical assessment of pubertal stage, and growth tempo from serial
height measures, and bone measures derived from peripheral quantitative computed
tomography (pQCT) and dual-energy X-ray absorptiometry (DXA) at 60-64 years of age
among 866 women and 792 men.
Methods: A first set of regression models investigated the relationships between puber-
tal timing and bone size, strength and density, adjusting for current height and weight,
smoking and adult socioeconomic position. To make an equivalent comparison between
men and women, the percentage difference in bone outcomes was calculated for a 5-
year difference in age at menarche, and in men a comparison between those who were
fully mature or pre-adolescent at 14.5 years. A second set of models investigated the per-
centage difference in bone outcomes for a 5-year difference in timing of peak height vel-
ocity (height tempo) derived from longitudinal growth modelling (Superimposition by
Translation and Rotation model; SITAR).
Results: After adjustment for current height and weight, a 5-year increase in age at me-
narche was associated with an 8% [95% confidence interval (CI) -17%, 0.5%, P ¼ 0.07)
lower trabecular volumetric bone mineral density (vBMD); men who were pre-
adolescent at 14.5 years had a 9%, (95% CI -14%, -4%; P ¼ 0.001) lower trabecular vBMD
compared with those who had been fully mature. Other confounders did not attenuate
these estimates further. Patterns of association were similar but somewhat weaker for
lumbar spine and total hip areal BMD. Age at peak height velocity was associated with
even larger differences in BMD in men and women, and was negatively associated with
bone size and strength.
VC The Author 2016. Published by Oxford University Press on behalf of the International Epidemiological Association. 1
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Conclusions: The association between later puberty and lower BMD persists into early
old age. The 9-10% lower trabecular vBMD in later compared with earlier maturers could
be clinically important given a rate of bone loss from midlife of 1-2% a year and the nega-
tive association between BMD and fracture.
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Introduction
Puberty is an important period for longitudinal and appos-
itional bone growth and mineral accrual: 20-30% of an in-
dividual’s total body bone mineral is accrued during the
pubertal growth spurt.1,2 It follows that ensuring optimal
growth during this period will be important for future
bone health and fracture risk.3,4 The extent to which pu-
bertal timing is related to later bone phenotype and frac-
ture risk has been investigated in a number of studies of
different types.5 Most recently, a large genomic analysis re-
vealed genetic correlations between timing of puberty in
men and women and a range of health outcomes, including
an inverse correlation with areal bone mineral density
(aBMD) of the lumbar spine in 33 000 individuals.6 Such
studies have the added benefit of avoiding any problems of
bias due to retrospective recall of pubertal timing.7 This
study supports the findings of some (for example 8–10),
but not all11 retrospective epidemiological studies of pre-
menopausal and postmenopausal women that have shown
that later age at menarche is associated with reduced
aBMD and increased fracture risk. The most recent of the
retrospective epidemiological studies is based on over
250 000 women from UK Biobank and reported a reduced
risk of self-reported doctor-diagnosed osteoporosis for
those with an early menarche;12 however, in men from the
same study, recalled timing of voice breaking was not
strongly associated with osteoporosis risk.12
Prospective longitudinal studies with gold-standard
bone phenotyping are required to fully understand rela-
tionships between pubertal timing, the development of
peak bone mass, and bone architecture and fracture risk.
There are a number of highly informative longitudinal
studies,2,13–17.but none have follow-up beyond the third
decade of life. Findings from studies using peripheral quan-
titative computed tomography (pQCT) or high-resolution
pQCT have reported small but significant, negative associ-
ations between cortical thickness, medullary area and bone
failure load in young women and age at menarche.13,14
Pubertal timing in younger cohorts, and especially in men,
has more often been assessed using measures of peak
height velocity (PHV), as clinical assessment of the Tanner
stages of physical development is rare.2,15,16,18 Later age at
PHV was associated with lower trabecular and cortical
volumetric BMD (vBMD) and with total body and radius
aBMD, in Swedish men aged 19 years;16,18 but by 24 years,
there had been substantial catch-up and only deficits in
aBMD and vBMD of the radius remained. These findings
suggest that any differences in bone due to timing of pu-
berty may be attenuated once catch-up growth has
occurred.17
Key Messages
• Puberty is an important period for bone growth and mineral accrual, but evidence from previous studies on pubertal
timing and adult bone health is inconclusive due to a lack of very long-term follow-up in studies with prospectively
acquired pubertal indicators and gold-standard bone outcomes.
• This birth cohort study is unique in having prospective data acquired in adolescence on puberty, and bone outcomes
in early old age derived from peripheral quantitative computed tomography and dual-energy X-ray absorptiometry,
on 1359 men and women.
• Later puberty, based on reported menarche, on clinically assessed pubertal stage or on growth tempo based on
growth curve analysis, was consistently associated with lower trabecular volumetric bone mineral density at the ra-
dius and lower areal bone mineral density of lumbar spine and total hip in participants aged 60-64 years.
• The 9-10% lower trabecular volumetric bone mineral density in later compared with earlier maturers may be clinically
important, given midlife rates of bone loss and a negative association between bone mineral density and fracture.
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The MRC National Survey of Health and Development
(NSHD), the oldest British birth cohort, initiated in 1946,
has markers of pubertal maturation based on clinical as-
sessments in adolescence, serial growth measures, and
bone measures at 60-64 years derived from pQCT, as well
as dual-energy X-ray absorptiometry (DXA), in a large
sample of men and women. We have previously described
in this cohort associations between height and weight gain
at different stages of growth, and bone phenotype at 60-64
years.19 Some of those differences described may have been
due to pubertal timing. Therefore the first aim of the cur-
rent study was to investigate the effect of age at menarche
and pubertal stage, acquired during adolescence, on pQCT
and DXA-derived bone outcomes in early old age. The se-
cond aim was to compare the these relationships with
those between pubertal growth markers of tempo, derived
using an instrument for longitudinal growth curve analysis
called the Superimposition by Translation and Rotation
(SITAR) model,20,21 and the bone parameters.
Methods
Sample
The NSHD is cohort study of 2815 men and 2547 women
followed up since their birth in a week in March 1946 in
England, Scotland and Wales. At the 24th follow-up, when
study members were aged between 60 and 64 years, 2856
were still alive and had a known current address in main-
land Britain. Participants were invited for assessment at
one of six clinical research facilities (CRFs); those unable
or unwilling to travel were offered a home visit by a re-
search nurse.22 A total 2229 participants out of the 2856
invited (78%) underwent assessment: 1690 attended a
CRF and the remaining 539 were seen in their homes.23 A
total of 778 participants had died. Of the remaining par-
ticipants, 570 were living abroad, 594 had previously with-
drawn from the study and 564 were lost to follow-up.
Bone health assessment at 60-64 years
Of those attending a CRF, 792 men and 866 women
underwent a DXA and 658 men and 697 women had a
pQCT scan of the radius (non-dominant side). DXA scans
were acquired in all six CRFs using the QDR 4500
Discovery (Hologic Inc, Bedford, MA), and in five CRFs
pQCT data using a XCT 2000 (Stratec, Pforzheim,
Germany) scanner were additionally collected. Details of
scan acquisition and cross-calibration have been previously
described.19 Standard manufacturer protocols were fol-
lowed for data acquisition. Machine variability between
centres was monitored using the European Spine Phantom
and the pQCT scanners using the European Forearm phan-
tom and, where necessary, cross-calibration was per-
formed. Standard manufacturer procedures were followed
for daily Quality Assurance/Quality Control and all phan-
tom and scan analyses were centralized to one centre (JEA)
for grading, analysis and collation of a harmonized data-
base. Repeat precision was determined in one centre and
was < 1% for DXA measurements, and for pQCT ranged
between 1% and 3%.
The bone outcomes for this analysis were pQCT-
derived measures at the radius distal 4% site of trabecular
and total vBMD and distal cross-sectional area (CSA), and
at the radius 50% site of CSA of the diaphysis and the me-
dullary cavity (medullary CSA), cortical vBMD and polar
strength strain index (SSI), an in vivo estimate of bone
strength.24 DXA-derived measurements of areal BMD for
lumbar spine (L1 L4) and total hip were also obtained.
Pubertal timing
Reports of pubertal timing were obtained in 1961 when
study members were aged 14-15 years (mean 14.5, range
14.3-15.2 years), when they underwent a medical examin-
ation and interview by a school doctor.25 Age at menarche
was obtained from mothers’ reports at the examination.
For 94 of the 188 girls who had not reached menarche by
the time of the examination, retrospective reports from
woman study members were later obtained from a postal
questionnaire at age 48. Age at menarche in years was used
for descriptive analyses, and modelled as months since
birth. In boys, the school doctor assessed: the development
of genitalia (advanced or complete, early or infantile);
voice breaking (completely broken, starting to break, not
yet started); visible pubic hair (profuse, sparse, none); and
visible axillary hair (yes or no). Based on these observa-
tions, boys were classified as fully mature (advanced devel-
opment of genitalia, profuse pubic hair and axillary hair,
and voice broken), advanced puberty (advanced develop-
ment of genitalia, but at least one other indicator not fully
mature), early puberty (early development of genitalia, and
some pubic or axillary hair or voice starting to break) and
pre-adolescent (infantile genitalia or early adolescent geni-
talia, no pubic or axillary hair and voice not broken).26
Individual patterns of height growth during puberty
were estimated using the SITAR model of growth curve
analysis.20,21 Data were collected using standardized
protocols at ages 2, 4, 6, 7, 11 and 15, and self-reported at
ages 20 and 26. To provide additional information at inter-
mediate ages, the NSHD data were augmented by height
data between 5 and 19 years from the ALSPAC cohort,27
as described by Cole et al.21 The SITAR model summarizes
each individual’s growth curve in terms of three
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parameters: size, tempo and velocity, each expressed rela-
tive to the mean curve. The model is estimated as a mixed
effects growth model with a cubic B-spline mean curve,
including both fixed and random (subject-specific) effects
for size, tempo and velocity. For the purposes of this paper,
we present only height tempo data, as these indicate the
timing of puberty which is the focus of the current paper.
A negative height tempo indicates earlier puberty, positive
indicates later puberty. Details of the other SITAR vari-
ables are given in Cole et al.21
Covariables
Current body size was assessed by height (m) and weight
(kg), according to a standard protocol. Smoking was split
into two categories, cigarette smokers versus non-smokers
at 60-64 years. According to the Registrar General’s social
class classification, social class was categorized based on
the participant’s occupation at age 53 years (or at other
ages if missing, n ¼ 4) to split those who were in the man-
ual social classes from those in the non-manual social
classes in adulthood. Other potential confounders or medi-
ators that were investigated in additional analyses were:
leisure-time physical activity (distinguishing those who
were most active (reporting vigorous leisure time activity
more than fibe times a month) from those less active (one
to four times a month) or inactive;28 and certain health
conditions assessed at age 60-64 years and detailed else-
where.29 We included a set of cardiometabolic health con-
ditions (cardiovascular disease, hypertension, raised
cholesterol and diabetes) and a second set of conditions
(liver disease, thyroid disease and psychiatric problems)
that may be relevant for bone.
In women, age when periods ceased naturally or be-
cause of hysterectomy or bilateral oophorectomy was ob-
tained from information on menstrual irregularity and date
of last menstrual period or any operation to remove the
uterus or ovaries. Information was collected in annual pos-
tal questionnaires from age 47 to 54 years and at 57 years,
and from face-to-face interviews with trained research
nurses at 43, 53 and 60-64 years of age.30
Statistical analysis
Of those who had a DXA or pQCT scan, 75% also had re-
ports of pubertal timing. R version 3.2 (www.R-project.
org) was used to fit the SITAR model and generate the
SITAR random effects. For all other analyses, Stata v10.1
was used. Regression models used natural logarithms for all
bone variables for comparative purposes. The coefficients
from these models are presented as the percentage differ-
ence in the bone outcome by category, or per unit increase.
Age at menarche and pubertal stage
Initial adjustments were for current body size (height and
weight at 60-64 years), and then for current smoking and
adult social class. In women, additional adjustments were
made for age at period cessation in a subset of women
where those data were available. In a set of further analyses,
we additionally adjusted for physical activity, cardiometa-
bolic conditions, and liver disease, thyroid disease and psy-
chiatric problems. We also re-ran the analyses excluding
11% with osteoporosis, based on bone density T-score from
the DXA scan  2.5 at spine, femoral neck or hip.29
To make an equivalent comparison between men and
women that compared those with the earliest and latest
pubertal timing, we calculated the percentage difference
in the bone outcomes for a 5-year difference in age at
menarche and the percentage difference between men
who were fully mature and pre-adolescent at age 14.5
years.
SITAR analysis of height tempo
Using the same participants with reported pubertal tim-
ing, the percentage difference in each of the bone out-
comes by the derived SITAR parameter of height tempo
was derived. The models first included height tempo un-
adjusted, and then additionally included current height
and weight. To compare the estimates for tempo with
those based on reported pubertal timing, we calculated
the percentage difference for a 5-year difference in timing
of puberty for women (10.5 to 15.5 years) and men (11.5
to 16.5 years).
Results
In the sample of 704 women and 655 men with at least one
bone outcome and reported pubertal timing, mean age at
menarche was 13.0 years (standard deviation (SD) 1 year,
2 months); and by 14.5 years, 26% of the boys were fully
mature, 30% were advanced, 34% were at an early stage
and 10% were still pre-adolescent. Descriptions of the
bone outcomes, puberty indicators and covariables are
shown in Table 1.
Mean differences in bone size, density and
strength by pubertal timing
In women, age at menarche was not associated with any
measures of CSA (diaphysis, medullary or distal radius);
nor was it associated with polar SSI (Table 2a). However,
later age at menarche was associated with lower total and
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Table 1. Characteristics of 655 men and 704 women from the MRC National Survey of Health and Development with at least one
bone measure and information on age at menarche or pubertal stage
Measures Men Women
No. Mean (SD) No. Mean (SD)
pQCT measures
pQCT-cortical sites
50% radius
Diaphysis CSA (mm2) 547 155 (23) 571 113 (16)
Medullary CSA (mm2) 546 43 (14) 569 35 (12)
Polar SSI (mm3) 543 348 (70) 572 211 (43)
pQCT-trabecular sites
Distal radius (4%)
Distal CSA (mm2) 547 171 (34) 566 133 (24)
pQCT-50% radius
Cortical vBMD (mg/cm3) 547 1159 (35) 572 1148.2 (39)
pQCT-distal radius (4%)
Trabecular vBMD (mg/cm3) 546 205 (41) 565 173 (42)
Total density vBMD (mg/cm3) 547 391 (67) 566 332 (71)
DXA measures
DXA aBMD (g/cm2)
Spine L1-L4 aBMD 652 1.05 (0.18) 699 0.95 (0.16)
Total hip aBMD 645 1.00 (0.14) 695 0.87 (0.13)
Current body size
Height (m) at 60-64 years 655 1.75 (0.06) 704 1.62 (0.06)
Weight (kg) at 60-64 years 655 85 (13.1) 704 72 (14.2)
Pubertal timing indicators
Age at menarche (years months) n/a 704 13years 0 months (1year 2 months)
% % %
Age at menarche n/a
9-10 24 3.4
11 91 12.9
12 214 30.4
13 243 34.5
14 98 13.9
15-19 34 4.8
Total (¼ 100%) 704
Pubertal stage (14.5 year)
Fully mature 168 25.6
Advanced 200 30.5
Early 222 33.9
Pre-adolescent 65 9.9
Total (¼ 100%) 655
Development of genitalia
Advanced or complete 368 56.2
Early 263 40.1
Pre-adolescent 24 3.7
Total (¼ 100%) 655
Broken voice
Completely broken 245 37.6
Starting to break 235 36.0
Not yet broken 172 26.4
Total (¼100%) 652
Pubic hair
Profuse 313 47.9
(Continued)
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trabecular vBMD and lumbar spine and total hip aBMD
(Table 2a).
In men, early puberty at 14.5 years was associated
with smaller diaphysis and medullary CSA, but not distal
CSA, and with lower polar SSI (Table 2b). Later pubertal
maturation was associated with lower mean values of tra-
becular vBMD and lumbar spine and total hip aBMD, and
higher mean values of cortical vBMD; but there were no
differences in total vBMD. All the indicators of pubertal
maturation (axillary hair, pubic hair and voice breaking)
Table 1. Continued
Measures Men Women
No. Mean (SD) No. Mean (SD)
Sparse 263 40.3
None 77 11.8
Total (¼ 100%) 653
Axillary hair
Yes 368 56.5
No 283 43.5
Total (¼ 100%) 651
Covariables
Smoking
No 584 89.9 626 89.4
Yes 66 10.1 74 10.6
Total (¼100%) 650 700
Own adult social class
Non-manual 473 72.2 562 79.8
Manual 182 27.8 142 20.2
Total (¼ 100%) 655 704
Age at period cessation (years)
27-39 40 7.0
40-44 57 9.9
45-49 131 22.9
50-52 159 27.7
53-55 126 22.0
56-62 60 10.5
Total (¼ 100%) 573
Table 2a. Mean and standard deviation (SD) for pQCT-derived outcomes at 60-64 years by age at menarche, women
Age at menarche
9-10 11 12 13 14 15-19 Totalsample P-value*
No. Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
pQCT
Distal CSA mm2 (4%) 566 132 (23) 132 (24) 130 (24) 134 (25) 136 (24) 129 (24) 133 (24) 0.3
Diaphysis CSA mm2 (50%) 571 111 (12) 113 (17) 115 (17) 111 (16) 112 (14) 112 (18) 113 (16) 0.3
Medullary CSA mm2 (50%) 570 31 (9) 34 (13) 37 (13) 36 (12) 35 (12) 35 (13) 35 (12) 0.7
Polar SSI mm3 (50%) 572 212 (34) 217 (45) 214 (45) 207 (42) 208 (39) 211 (39) 211 (43) 0.1
Total vBMD mg/cm3 (4%) 566 351 (82) 339 (69) 340 (74) 322 (70) 318 (64) 337 (69) 332 (71) 0.01
Trabecular vBMD mg/cm3 (4%) 565 178 (40) 177 (41) 179 (46) 169 (41) 168 (35) 158 (40) 173 (42) 0.004
Cortical vBMD mg/cm3 (50%) 572 1157 (33) 1146 (44) 1146 (40) 1149 (40) 1152 (33) 1151 (40) 1148 (39) 0.5
DXA
Lumbar spine aBMD g/cm2 699 0.98 (0.14) 0.98 (0.18) 0.95 (0.16) 0.95 (0.16) 0.92 (0.15) 0.91 (0.16) 0.95 (0.16) 0.006
Total hip aBMD g/cm2 695 0.90 (0.14) 0.90 (0.13) 0.87 (0.12) 0.86 (0.13) 0.85 (0.12) 0.84 (0.12) 0.87 (0.13) 0.001
*P-values from regression models with logged bone outcomes and including age at menarche in months since birth as a continuous variable.
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showed similar patterns with these bone parameters
(Supplementary Tables 1-4, available as Supplementary
data at IJE online).
Regression models for age at menarche and
pubertal stage
In women with complete data (n ¼ 573 for pQCT-derived
measures and 704 for DXA-derived measures), a 5-year in-
crease in age at menarche was associated with an 11%
(95% CI -19%, -3%, P ¼ 0.01) lower trabecular vBMD
(Table 3a, model 1). Adjusting for current height and
weight attenuated this estimate somewhat (-8%, 95% CI -
17%, 0.5%; P ¼ 0.07) (Table 3a, model 2). There was no
further attenuation after adjusting for smoking and social
class (Table 3a, model 3). The associations for total vBMD
and aBMD in lumbar spine and total hip were in the same
direction but slightly weaker; no other associations were
observed. In the subset of women with age at period cessa-
tion, the association between age at menarche and BMD
was attenuated after adjustment for body size, particularly
for trabecular vBMD, but not on further adjustment for
age at period cessation or other confounders
(Supplementary Table 5, available as Supplementary data
at IJE online).
In men (n ¼ 550 for pQCT-derived measures and 655 for
the DXA-derived measures), the differences in CSA between
those assessed as pre-adolescent compared with those fully
mature was greatest for medullary CSA (-10%, 95% CI -
19%, -1%; P ¼ 0.02); adjusting for height and weight atte-
nuated these differences, but additionally adjusting for smok-
ing and social class did not (Table 3b, models 1-3). The
corresponding difference in trabecular vBMD was -9%
(95% CI -15%, -4%; P ¼ 0.001), with almost no attenu-
ation after adjustment for current height and weight (-9%,
95% CI -14%, -4%; P ¼ 0.001) or for smoking and social
class (Table 3b models 1-3). In contrast, those assessed as
pre-adolescent had higher cortical vBMD (0.9%, 95% CI
0.1, 1.7, p¼ 0.02); this was not attenuated after further ad-
justment. Negative associations were also seen for aBMD in
lumbar spine and total hip, but these were attenuated after
adjustment for confounders. The difference in polar SSI was
-6% (95% CI -11%, -0.8%; P ¼ 0.02), and this was also
reduced after adjustment for body size (-4%, 95% CI -9%,
0.5%; P ¼ 0.08) but not after adjusting for smoking and so-
cial class (Table 3b, models 1-3). Regression models substi-
tuting pubertal stage for the separate pubertal indicators in
turn (axillary hair, public hair, genitalia and broken voice)
all showed similar patterns. The results remained the same
upon additional adjustments for physical activity and certain
health conditions (cardiometabolic disorders, liver disease,
thyroid disease or psychiatric problems). Excluding those
with osteoporosis had only a minor effect on the estimates.
Regression models for SITAR growth parameters
The negative coefficients for height tempo in men and
women are consistent with our findings of later pubertal
timing, being associated with lower trabecular vBMD, and
spine and total hip aBMD (Table 4). Height tempo was
also associated with total and trabecular vBMD, and with
spine and total hip aBMD in men. In most cases the height
tempo effects were larger than those based on reported pu-
bertal timing, though the confidence intervals were also
Table 2b. Mean and standard deviation (SD) for pQCT-derived and DXA-derived outcomes at 60-64 years by pubertal stage at
14.5 years, men
Pubertal stage
Fully mature Advanced Early Pre-adolescent Total sample P-value
No. Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
pQCT
Distal CSA mm2 (4%) 547 172 (38) 174 (31) 170 (33) 167 (32) 171 (34) 0.3
Diaphysis CSA mm2 (50%) 547 159 (25) 155 (21) 152 (22) 153 (22) 154 (23) 0.01
Medullary CSA mm2 (50%) 546 45 (16) 44 (14) 41 (12) 41 (14) 43 (14) 0.02
Polar SSI mm3 (50%) 543 358 (77) 349 (64) 342 (72) 340 (61) 348 (70) 0.03
Total vBMD mg/cm3 (4%) 547 403 (71) 384 (67) 388 (64) 397 (71) 391 (67) 0.3
Trabecular vBMD mg/cm3 (4%) 546 216 (43) 205 (41) 201 (40) 197 (41) 205 (41) < 0.001
Cortical vBMD mg/cm3 (50%) 547 1153 (37) 1159 (35) 1161 (33) 1162 (31) 1159 (35) 0.03
DXA
Lumbar spine aBMD g/cm2 652 1.08 (0.18) 1.04 (0.19) 1.05 (0.17) 1.01 (0.15) 1.05 (0.18) 0.02
Total hip aBMD g/cm2 645 1.02 (0.14) 1.00 (0.16) 0.99 (0.14) 0.97 (0.15) 1.00 (0.14) 0.01
*P-values from regression models with logged bone outcomes and including pubertal stage as a continuous variable.
International Journal of Epidemiology, 2016, Vol. 0, No. 0 7
 at U
niversity College London on Septem
ber 29, 2016
http://ije.oxfordjournals.org/
D
ow
nloaded from
 
Table 3a. Percentage difference in DXA-derived and pQCT-derived outcomes for a 5-year difference (diff) in age at menarche ,
additionally adjusted for current height and weight, smoking and adult social class, women
Unadjusted Adjusted for
height & weight
Additionally adjusted for
smoking and adult social class
No. % diff 95% CI P-value % diff 95% CI P-value % diff 95% CI P-value
pQCT measures
pQCT-cortical sites
50% radius
Diaphysis CSA (mm2) 567 2.5 7.1, 2.12 0.3 3.3 7.5, 1.0 0.1 3.3 7.6, 0.9 0.1
Medullary CSA (mm2) 565 0.8 10.4, 12 0.9 2.2 13.4, 8.9 0.7 2.5 13.7, 8.7 0.7
Polar stress strain
index (mm3)
568 4.1 10.6, 2.5 0.2 4.9 11.1, 1.2 0.1 4.9 11.1 to1.3 0.1
pQCT-trabecular sites
Distal radius (4%)
Distal CSA (mm2) 562 3.6 2.7, 9.9 0.3 2.0 4.1, 8.0 0.5 2.1 3.9, 8.2 0.5
pQCT-50% radius
Cortical vBMD
(mg/cm3)
568 0.2 0.9, 1.4 0.7 0.4 0.8, 1.5 0.5 0.4 0.7, 1.6 0.5
pQCT-distal
radius (4%)
Trabecular
vBMD (mg/cm3)
561 11 19.3, -2.5 0.01 8.0 16.6, 0.5 0.07 8.1 16.7, 0.5 0.07
Total density
vBMD (mg/cm3)
562 8 15.1, -0.9 0.03 5.5 12.7, 1.7 0.1 5.7 12.9, 1.5 0.1
DXA measures
DXA aBMD (g/cm2)
Spine L1-L4 aBMD 695 7.2 12.4, -2.1 0.006 4.8 9.9, 0.3 0.06 4.8 9.9, 0.3 0.06
Total hip aBMD 691 8.2 12.6, -3.8 < 0.001 4.3 8.3, 0.3 0.04 4.2 8.1 to0.1 0.04
Table 3b. Percentage difference in DXA-derived and pQCT-derived outcomes comparing pre-adolescent with fully mature males
at 14.5 years, additionally adjusted for current height and weight, smoking and adult social class, men
Unadjusted Adjusted for height &
weight
Additionally adjusted for
smoking and adult social class
No. % diff 95% CI P-value % diff 95% CI P-value % diff 95% CI P-value
pQCT measures
pQCT-cortical sites
50% radius
Diaphysis CSA (mm2) 542 5.0 8.7, -1.2 0.009 3.8 7.1, 0.4 0.03 3.8 7.1, 0.5 0.03
Medullary CSA (mm2) 541 9.9 18.6, -1.3 0.02 8.4 16.8, 0.02 0.05 8.5 .03 0.046
Polar stress strain index (mm3) 538 6.1 11.4, -0.8 0.02 4.3 9.0, 0.5 0.08 4.4 9.0, 0.3 0.07
pQCT-trabecular sites
Distal radius (4%)
Distal CSA (mm2) 542 2.7 8.1, 2.7 0.3 1.8 7.1, 3.5 0.5 1.7 6.9, 3.6 0.5
pQCT-50% radius
Cortical vBMD (mg/cm3) 542 0.9 0.1, 1.7 0.02 0.8 0.1, 1.6 0.04 0.8 0.02, 1.6 0.04
pQCT-distal radius (4%)
Trabecular vBMD (mg/cm3) 541 9.2 14.7, -3.8 0.001 8.9 14.4, 3.5 0.001 9.2 14.6 to3.7 0.001
Total density vBMD (mg/cm3) 542 1.5 6.0, 3.1 0.5 1.3 5.9, 3.2 0.6 1.6 6.1, 3.0 0.5
DXA measures
DXA aBMD (g/cm2)
Spine L1-L4 aBMD 647 4.5 8.5, -0.4 0.03 2.7 6.4, 1.1 0.2 2.6 6.4, 1.2 0.2
Total hip aBMD 640 4.5 8.0, -1.0 0.01 2.5 5.6, 0.7 0.1 2.6 5.7, 0.5 0.1
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wider and the significance levels broadly similar (Figure 1).
Height tempo in men and women was inversely associated
with diaphysis CSA and polar SSI; additionally, in men it
was negatively associated with medullary CSA. These asso-
ciations were attenuated by adjustment for current body
size in men but not women.
Discussion
In a large British birth cohort, later puberty, determined
at clinical assessments in adolescence, was associated with
lower trabecular vBMD at the radius and lower aBMD at
the lumbar spine and hip in early old age. The effect was
seen across the range of pubertal maturation and was of a
similar size in men and women, explaining 9-10% of the
variation in vBMD between the earliest and latest
maturers. In men but not women, later puberty was also
associated with reduced bone size and strength, although
these associations were weaker than for vBMD. Replacing
these pubertal indicators with SITAR-derived height tempo
gave similar results and the associations were, on
the whole, stronger. Later puberty was again negatively
associated with trabecular vBMD and aBMD at both sites.
Table 4. Percentage difference (diff) in DXA-derived and pQCT-derived outcomes for a 5-year difference in height tempo
Women Men
Height tempo Height tempo
Unadjusted Adjusted for
height & weight
Unadjusted Adjusted for
height & weight
%
diff
95%
CI
P-
value
%
diff
95%
CI
P-
value
%
diff
95%
CI
P-
value
%
diff
95%
CI
P-
value
pQCT measures
pQCT-cortical sites
50% radius
Diaphysis CSA (mm2) 4.9 10.6, 0.7 0.09 6.9 12, -1.8 0.009 6.9 13.5, -0.3 0.04 8.8 14.8, -2.8 0.004
Medullary CSA (mm2) 1.7 15.9, 12.5 0.8 6.4 20.5, 7.7 0.4 16.5 31.8, -1.2 0.04 19.3 34.2, -4.4 0.01
Polar stress strain index
(mm3)
7.5 15.6, 0.7 0.07 9.8 17.3, -2.3 0.01 8.3 17.5, 1 0.08 10.9 19.3, -2.4 0.01
pQCT-trabecular sites
Distal radius (4%)
Distal CSA (mm2) 1.6 6, 9.2 0.7 1.7 8.9, 5.5 0.7 3.2 6.5, 12.9 0.5 1.9 7.6, 11.4 0.7
pQCT-50% radius
Cortical vBMD (mg/cm3) 0.6 2, 0.8 0.4 0.5 1.9, 0.9 00.5 0.7 0.7, 2.1 0.3 0.6 0.8, 2 0.4
pQCT-distal radius (4%)
Trabecular vBMD
(mg/cm3)
22.2 32.7, 11.8 < 0.001 18.4 28.9, 7.9 0.001 21.4 31.2, 11.6 < 0.001 20.6 30.4, 10.8 < 0.001
Total density vBMD
(mg/cm3)
11.0 19.7, 2.4 0.01 7.5 16.2, 1.1 0.09 9.6 17.5, -1.7 0.02 9.2 17.1, -1.2 0.02
DXA measures
DXA aBMD (g/cm2)
Spine L1-L4 aBMD 13.9 20.4, 7.5 < 0.001 11.8 18, 5.5 < 0.001 9.7 16.9, 2.4 0.009 9.7 16.6, 2.9 0.006
Total hip aBMD 9.9 15.5, 4.2 0.001 5.9 10.9, 0.9 00.02 7.0 13.2, 0.9 .03 6.4 11.9, 0.8 0.02
Figure 1 Percentage difference in peripheral trabecular vBMD by a)
pubertal timing and b) height tempo for women and men unadjusted
and adjusted for height and weight.
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In contrast to the analysis with reported age at menarche,
bone area and strength were also lower in women with
later pubertal growth. Similar relationships for bone size
and strength were found in men.
Of the variance in BMD, 60-80% is explained by gen-
etics,5,6,31,32 which could explain the close relationships
between vBMD and tempo or pubertal timing. During
growth, the cross-section of a bone will also be determined
by allometric scaling to height growth and to weight
gain.21 Using SITAR in both men and women, later pu-
berty was associated at the diaphysis, with a smaller, less
strong, bone, presumably because of the extended limb-
growth period in these individuals. Medullary CSA was
also smaller in later-maturing men, indicating proportional
growth of the periosteal and endosteal surfaces. In women,
no associations with medullary CSA existed. There are two
possible explanations for this. First, the lack of expansion
of the medullary cavity in females during pubertal growth
is often attributed as preparation for pregnancy, being less
driven by biomechanical adaptation to height growth as is
the case in men. Second, at the time of measurement this
group of women were all post-menopausal. Bone loss with
ageing occurs at the endosteal surface, and so any relation-
ships between puberty and medullary area may have been
attenuated by bone loss that had already occurred.
These are important findings as, once skeletal maturity
is reached and longitudinal growth ceases, bones grow up
to 2 years more in width and 4 years more in mineral con-
tent,2and thereafter the skeletal reservoir is set for adult
life. As such, the amount of bone an individual has at the
end of growth is a determinant of future fracture risk.3,4
Further to this, the vBMD-tempo association is interesting
in that vBMD was  20% less in those with late
compared with early puberty. Given that a 1-SD reduction
in BMD results in a doubling of fracture risk,33 the differ-
ences in the current study may represent a significant
increased risk of fracture between the two extremes. There
are fewer data relating SSI to fracture risk, though in men
with fractures compared with those without, SSI was asso-
ciated with incident fracture (hazard ratio 2.3, 95% CI
1.3, 4.1).34
The main difference between the two methods of assess-
ment for pubertal timing is that we used a single event to
mark puberty, whereas the SITAR analysis used longitu-
dinal growth data. This difference in characterization of
pubertal growth may explain why more associations were
found between height tempo and bone size and strength
than for measures of reported pubertal timing. Because the
tempo parameter modelled pubertal timing based on the
whole of adolescent growth, and because longitudinal
growth is a more proximal indicator of growth in bone
cross-section and mineral apposition than the development
of secondary sexual characteristics, these differences may
have a biological basis and reflect the differential impact of
sex hormones and other endocrine factors, rather than sim-
ply being due to errors of recall or measurement. Being
able to compare these two methods of assessment and rela-
tionships with bone is a unique feature of the NSHD. A se-
cond advantage of this modelling technique is that men
and women were aligned on the same developmental scale
to determine timing, which may have improved accuracy
of relationships described.
As in the current study, later menarche is associated
with lower aBMD in some studies.8,9,13,14 Since then there
have been some prospective studies that have used pQCT
and followed women into late adolescence or early-mid
adulthood.35 Again, results were not conclusive. The most
consistent finding was that later age of menarche was asso-
ciated with greater endosteal circumference (i.e. medullary
area) and thinner cortices. A study using high-resolution
pQCT reported a negative association between total and
cortical vBMD. This is in contrast to our findings which
found no association in older women between timing of
puberty and cortical bone outcomes.
The UK Biobank study is the largest to date to report
the relationship between pubertal timing and osteoporosis
risk. In women, self-reported puberty was categorized into
early, normal and late. In the late puberty group, incidence
of self-reported osteoporosis was increased, and in the
early group it was reduced. This confirms previous epi-
demiological studies showing late menarche to be a risk
factor for fracture.36 The associations found in our study
would be consistent with these findings of increased risk of
fractures and osteoporosis.
In males in the GOOD study, with the exception of cor-
tical vBMD, later age at PHV was not associated with any
DXA or pQCT outcome at age 23-25 years (around the
age of peak bone mass).17 This is in contrast to the current
study, which showed associations particularly between pu-
bertal timing and bone size and distribution at the cortical
site. In the UK Biobank, no associations were found be-
tween reported time of voice breaking and self-reported
osteoporosis.12
Strengths and limitations
The main strength of this study is that it is the only one to
have collected growth and pubertal information prospect-
ively and to have been able to relate those measures to
gold-standard bone outcomes in early old age. Second,
pQCT as well as DXA measurements were taken and re-
sults were consistent at both weight-bearing sites (lumbar
spine and total hip by DXA) and non weight-bearing sites
(radius by pQCT). Peripheral QCT has advantages over
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DXA in that measures are volumetric and not size depend-
ent, and separate measures of trabecular and cortical com-
partments allow assessment of the size and distribution of
bone, which are important predictors of bone strength.
Third, this relatively large British sample included men and
women, and the narrow age range of the sample at assess-
ment limits potential confounding by age.
One limitation is that bone was only measured in early
old age, so we do not know whether the associations with
various bone outcomes were the result of peak bone mass or
adult bone loss, although we (and others5) would hypoth-
esize that the former would be more likely. A second limita-
tion is that we cannot translate our findings of pubertal
timing and future bone phenotype to fracture risk until suffi-
cient events have accrued; however, it is known that lower
BMD is predictive of future osteoporotic fracture.33,37,38 A
third limitation of the study was that these analyses were
limited to participants who attended a clinic visit. The clinic
group were taller and the women were lighter than those
who had only a home visit, and have also been found to
have fewer health conditions.23 However there is no reason
to suspect that the associations between pubertal markers
and the bone outcomes should differ between the two
groups at this stage of early ageing. A fourth limitation is
that the sample were all born in the early post-war period;
therefore our findings may not be generalizable to later-born
cohorts. The decline in the age at menarche slowed from 2
months a decade to reach 12.8 years in the 1950s, and has
been relatively stable since;39 however, we do see a secular
decline in pubertal timing between NSHD participants born
in 1946 and ALSPAC participants born 1991-92.21
Conclusions
The association between the timing of puberty and BMD
persists into early old age. The 9-10% lower peripheral tra-
becular vBMD in later compared with earlier maturers
could be clinically important, given a rate of bone loss
from midlife of 1-2% a year and the negative association
between BMD and fracture.
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